Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atezolizumab in Advanced Solid Tumors
NCT02458638Phase 2Completed
- Sponsor
- Roche
- Start
- Jul 2015
- Primary completion
- Apr 2018
- Modality
- Monoclonal Antibodies
- Countries
- 18
01
Overview
A Phase 2 trial of atezolizumab in solid tumor (advanced stage), sponsored by Roche. Started Jul 2015; status: completed.
02
Drugs
atezolizumab
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT02458638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02458638.